Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients.
Tirelli, U, Franzini, M, Valdenassi, L et al.·European review for medical and pharmacological sciences·2021
This study tested whether a treatment called oxygen-ozone autohemotherapy (a procedure where blood is mixed with ozone gas and returned to the body) could help reduce fatigue in 100 people with post-COVID symptoms. On average, the treatment reduced fatigue symptoms by 67%, and about 40% of patients reported nearly complete recovery from fatigue. The benefits appeared similar in men and women.